Atrium Medical Seeks Ninth Circuit Reassessment in $52.8 Million Patent Royalties Dispute

Atrium Medical Corp. is pushing for the full Ninth Circuit Court of Appeals to reexamine a panel decision that favored C.R. Bard Inc. in a high-stakes legal battle over patent royalty agreements. The $52.8 million lawsuit hinges on claims of patent misuse, where Atrium argues that the panel overlooked critical evidence and the district court’s findings. The outcome of this reconsideration could significantly impact the parties involved and broader patent legal standards. For further details, explore the full article.